Total Payments
$83,802
2024 Payments
$26,346
Companies
32
Transactions
812
Medicare Patients
1,005
Medicare Billing
$234,942
Payment Breakdown by Category
Other$64,000 (76.4%)
Food & Beverage$16,256 (19.4%)
Travel$3,299 (3.9%)
Education$246.87 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $61,725 | 27 | 73.7% |
| Food and Beverage | $16,256 | 745 | 19.4% |
| Travel and Lodging | $3,299 | 32 | 3.9% |
| Honoraria | $2,275 | 1 | 2.7% |
| Education | $246.87 | 7 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $59,657 | 146 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $10,634 | 42 | $0 (2024) |
| Corium, LLC | $1,430 | 68 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,409 | 35 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,147 | 42 | $0 (2024) |
| ITI, Inc. | $1,033 | 40 | $0 (2023) |
| Axsome Therapeutics, Inc. | $960.87 | 50 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $883.87 | 46 | $0 (2024) |
| Lundbeck LLC | $783.98 | 52 | $0 (2024) |
| Alkermes, Inc. | $765.63 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,346 | 240 | ABBVIE INC. ($11,734) |
| 2023 | $50,347 | 221 | AbbVie Inc. ($47,217) |
| 2022 | $2,830 | 137 | Corium, LLC ($457.17) |
| 2021 | $2,078 | 120 | AbbVie Inc. ($348.99) |
| 2020 | $317.69 | 18 | Otsuka America Pharmaceutical, Inc. ($132.31) |
| 2019 | $1,097 | 41 | Otsuka America Pharmaceutical, Inc. ($282.53) |
| 2018 | $636.53 | 25 | Indivior Inc. ($204.96) |
| 2017 | $149.00 | 10 | Lundbeck LLC ($55.33) |
All Payment Transactions
812 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 12/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: CNS | ||||||
| 12/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $7.39 | General |
| Category: Neurology | ||||||
| 12/06/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: ADHD | ||||||
| 12/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.86 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $1.82 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $73.94 | General |
| Category: Central Nervous System | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $18.47 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $5.75 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $3.78 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $1.14 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/02/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Neuroscience | ||||||
| 11/27/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $7.34 | General |
| Category: ADHD | ||||||
| 11/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Neuropsychiatry | ||||||
| 11/22/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: CNS | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Central Nervous System | ||||||
| 11/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $5.67 | General |
| Category: Neuroscience | ||||||
| 11/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $1.96 | General |
| Category: Neuroscience | ||||||
| 11/18/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $19.04 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 255 | 888 | $108,632 | $56,385 |
| 2022 | 2 | 206 | 929 | $115,460 | $59,584 |
| 2021 | 3 | 268 | 971 | $92,100 | $58,895 |
| 2020 | 2 | 276 | 1,154 | $106,710 | $60,078 |
Total Patients
1,005
Total Services
3,942
Medicare Billing
$234,942
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 410 | $61,400 | $32,554 | 53.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 102 | 420 | $41,925 | $20,159 | 48.1% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 27 | 29 | $4,147 | $2,921 | 70.4% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 26 | 29 | $1,160 | $749.94 | 64.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 464 | $69,170 | $36,996 | 53.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 103 | 465 | $46,290 | $22,588 | 48.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 118 | 457 | $62,250 | $38,764 | 62.3% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 122 | 484 | $25,800 | $18,093 | 70.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 30 | $4,050 | $2,039 | 50.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 138 | 573 | $77,705 | $38,717 | 49.8% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 138 | 581 | $29,005 | $21,361 | 73.6% |
About Dr. James Cho, M.D
Dr. James Cho, M.D is a Psychiatry healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1376706754.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Cho, M.D has received a total of $83,802 in payments from pharmaceutical and medical device companies, with $26,346 received in 2024. These payments were reported across 812 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($61,725).
As a Medicare-enrolled provider, Cho has provided services to 1,005 Medicare beneficiaries, totaling 3,942 services with total Medicare billing of $234,942. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Saint Louis, MO
- Active Since 07/07/2008
- Last Updated 12/14/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1376706754
Products in Payments
- VRAYLAR (Drug) $59,898
- Qelbree (Drug) $10,589
- REXULTI (Drug) $1,806
- CAPLYTA (Drug) $1,552
- Azstarys (Drug) $973.09
- Auvelity (Drug) $892.18
- TRINTELLIX (Drug) $593.27
- SPRAVATO (Drug) $534.11
- Austedo XR (Drug) $522.79
- AUSTEDO (Drug) $516.12
- ARISTADA (Drug) $513.49
- AZSTARYS (Drug) $457.17
- QUVIVIQ (Drug) $411.21
- INGREZZA (Drug) $393.74
- INVEGA SUSTENNA (Drug) $349.76
- NUPLAZID (Drug) $310.21
- LATUDA (Drug) $276.24
- BELSOMRA (Drug) $230.34
- LYBALVI (Drug) $215.70
- Lucemyra/Lofexidine (Drug) $182.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Saint Louis
Dr. Mohd Malik, M.d, M.D
Psychiatry — Payments: $1.8M
Psychiatry $1.8M
Adam Sky, Md, MD
Psychiatry — Payments: $1.4M
Psychiatry $1.4M
Dr. Junaid Syed, M.d, M.D
Psychiatry — Payments: $1.1M
Psychiatry $1.1M
Dr. Michael Stotler, Md, MD
Psychiatry — Payments: $299,451
Psychiatry $299,451
Dr. Naji Chaaya Salloum, M.d, M.D
Psychiatry — Payments: $236,374
Psychiatry $236,374
Dr. Devnandini Rastogi, Md, MD
Psychiatry — Payments: $230,240
Psychiatry $230,240